Vergoeding 2014-2018 voor ATC-subgroep A10AB : Snelwerkende insulines voor injectie
- Raming voor de totale Zvw-populatie
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| A10AB01 Insuline (humaan) (Insuman rapid ®) | 800.560 | 718.630 | 660.340 | 558.020 | 484.520 |
| A10AB04 Insuline lispro (Humalog ®) | 6.533.400 | 6.607.800 | 7.020.200 | 7.076.600 | 6.877.800 |
| A10AB05 Insuline aspart (Novorapid ®) | 43.366.400 | 44.177.100 | 44.727.900 | 45.342.600 | 45.006.500 |
| A10AB06 Insuline glulisine (Apidra ®) | 3.507.200 | 3.729.400 | 3.883.500 | 3.840.100 | 3.684.700 |
| Totaal | 54.207.560 | 55.232.930 | 56.291.940 | 56.817.320 | 56.053.520 |